Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer- United Kingdom

doi 10.1038/bjc.1989.356

Full Text

Abstract

Available in

Categories

Cancer Research

Date

November 1, 1989

Authors

Publisher

Springer Science and Business Media LLC

Related search

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry

Molecular Biology

English

Cancerous Inhibitor of Protein Phosphatase 2A Regulates Cisplatin Resistance in Ovarian Cancer

Oncology Letters

Cancer Research

English

Resensitization of Cisplatin Resistance Ovarian Cancer Cells to Cisplatin Through Pretreatment With Low‐dose Fraction Radiation

Cancer Medicine

Cancer Research

Nuclear Medicine

English

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology

Cancer Research

English

Does Carboplatin Change to Cisplatin?

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

English

Toxicity of Carboplatin vs. Cisplatin

Practica Otologica, Supplement

Otorhinolaryngology

English

Population Pharmacokinetc/Pharmacodynamic Modeling of Paclitaxel and Carboplatin in Ovarian Cancer

Clinical Cancer Research

Cancer Research

English

Heparin Antagonizes Cisplatin Resistance of A2780 Ovarian Cancer Cells by Affecting the WNT Signaling Pathway

English